Karyopharm Therapeutics (KPTI) Tops Q3 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Karyopharm Therapeutics (KPTI) Files $200M Mixed Securities Shelf
November 8, 2016 8:56 AM ESTKaryopharm Therapeutics (Nasdaq: KPTI) filed a registration with the U.S. SEC to sell up to $200 million of mixed securities.
... More


